NCT03304470View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

March 5, 2018

Study Completion Date

March 5, 2018

Conditions

Atopic Dermatitis

Interventions

DRUG

ATx201 2% Cream

Anhydrous Cream

DRUG

ATx201 Cream Vehicle

Anhydrous Cream

Trial Locations (1)

H2K 4L5

Innovaderm Research Inc, Montreal

Sponsors

Lead Sponsor

UNION therapeutics

All Listed Sponsors

lead

UNION therapeutics

INDUSTRY

NCT03304470 - A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter